EN

Milestones

Explore our milestones and our journey of growth.

2026

  • Sunway Biotech Acquire Weider Global Nutrition Acquisition Completes Bora Group’s Dual-Engine Growth Strategy Across Entities
  • Ankascin 568 recognized as Vitafoods Europe Innovation Awards Finalist
  • EXOSMART Capsules Wins Gold at the 2026 Brain Health Innovation Product Awards

2025

  • Bora Health Partners with Dr. Reddy’s Laboratories Ltd.
  • US FDA GRAS Approval for NTU101

2024

  • Ankascin products in the USA were honored as finalists in the 2024 NutraIngredients USA Awards.
  • “Launched the new Dr. B brand & established an agency agreement with Yen Yeh Research.

2023

  • Gained Taiwan’s health certification for anti-aging with our red yeast rice products.
  • Achieved 2023 NutraIngredients Awards recognition for Ankascin and other red yeast products in the U.S. and Asia.
  • Advanced red yeast rice standardization through a new chapter in the US Pharmacopeia.
  • Established a joint venture, GTSW Bio, with Great Tree Pharmacy.
  • Joined the Bora Group and secured a stake in Bora Federal.

2022

  • U.S. red yeast rice products reached 2022 NutraIngredients USA Awards finalist status.
  • Taiwanese red yeast rice awarded the SNQ National Quality Bronze Award.
  • Secured the 2022 Taiwan BIO Gold Award for industry excellence in biotechnology.

2021

  • SunWay is listed on Taiwan Emerging Stock Market
  • Cooperation with US Florida brand owner
  • Ranked 9th in the Biotechnology Service Industry in Taiwan’s TOP 5000 Largest Enterprises

2020

  • Taiwanese product red yeast rice won the Taiwan Health Food Society Nutrition and Health Food Innovation Award.
  • SunWay is awarded “Taiwan BIO Awards- Emerging Company of the Year“
  • Cooperation with Belgium distributor

2019

  • Obtained D & B’s business operation capability certification
  • Cooperate with NTU Hospital to conduct clinical trials related to probiotics and H. pylori
  • NTU 101 is honored to be as the cover of Food & Function Journal
  • Red yeast rice ANKASCIN 568-R was invited to write a review
  • New red yeast rice raw material 568-P developed

2018

  • Red Yeast Extract ANKASCIN 568-R Granted New Dietary Ingredient Recognition by the U.S. FDA (#1071)
  • Accomplished clinical trials on the probiotic Vigiis 101-LAB ingredient’s (gut transition effects)

2017

  • Acquired 2nd health claim certificate for new red yeast capsules in Taiwan
  • A food supplement containing ANKASCIN® 568-R was approved by Italian authorities
  • Clinical results on red yeast ingredient’s blood pressure effects were accepted by a peer-reviewed journal
  • SunWay’s management system has been certified by TÜV Rheinland
  • Established Songshan Lake SunWay Biotechnology in Dongguan, Guangdong
  • Initial public offering

2016

  • Acquired health claim certificate for new red yeast capsules in Taiwan
  • Clinical results on red yeast ingredient’s blood sugar effects were accepted by a peer-reviewed journal
  • Accomplished clinical trial on the probiotic Vigiis 101-LAB ingredient (gut microbiota effects)

2015

  • The red yeast extract (ANKASCIN 568-R) was accepted by the US FDA as an NDI (New Dietary Ingredient)
  • Two clinical trials were completed in Taiwan, demonstrating ANKASCIN 568 Plus+ was effective in lowering blood glucose and blood lipids (total cholesterol and low-density lipoprotein cholesterol)
  • Red yeast and Lactobacillus ingredient supply and contract manufacturing of private label finished products.

2014

  • Development of Lactobacillus soft sweets.

2013

  • A red yeast product (ANKASCIN 568) was granted the Health Food Permit (No. A00231).

2012

  • The main facility was expanded and certified with ISO 22000 and HACCP.
  • Application and development of non-active Lactobacillus, collagen powder, and herbal tablets.

2011

  • The fermented manufacturing processes of red yeast-related products were granted patents and certificates from multiple nations.

2010

  • Probiotic products were awarded the Certification of Symbol of National Quality (SNQ).
  • Red yeast capsulate products were granted the Certification of Halal and the US federal trademark “HCW”.

2008 - 2009

  • Developing red yeast products in capsule
  • The research and technology of Monascus purpureus NTU 568 (red yeast) and Lactobacillus paracasei subsp. paracasei NTU 101 (probiotics) were exclusively authorized by National Taiwan University.
  • Red yeast (Monascus purpureus) beverages were awarded the Certification of Symbol of National Quality (SNQ).

2007

  • SunWay Biotech Co., LTD. was established and its facility was qualified for GMP certification.
Language